System and method for augmenting a humoral immune response

• US 20080086292A1
• Filed: 08/14/2007
• Published: 04/10/2008
• Est. Priority Date: 12/03/2004
• Status: Abandoned Application

• Current Assignee: Searete LLC (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Jung, Edward, Wilson, Richa, Myhrvold, Nathan, Wood, Lowell, Ishikawa, Muriel
• Application Number:
  US11/893,276
• Publication Number:
  US 20080086292A1
• Time in Patent Office: Days
• US Class Current: 703/11
• CPC Class Codes: A61K 31/55 having seven-membered rings, e.g. azelastine, pentylenetetrazole
• CPC Class Codes: A61K 39/00 Medicinal preparations containing antigens or antibodies materials for immunoassay G01N33/53
• CPC Class Codes: A61K 39/02 Bacterial antigens
• CPC Class Codes: Y02A 50/30 Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The present application relates, in general, to a system and/or method for detection and/or treatment.

Claims

1. A method, comprising:

identifying an association of at least a computable portion of one or more agents with at least a part of an immune response;

projecting a pattern of one or more changes relating to the at least a computable portion of the one or more agents; and

selecting one or more immune response components in response to the projecting.

2. The method of claim 1, wherein the selecting one or more immune response components further comprises:

selecting at least a part of one or more of a macrophage, a neutrophil, a cytotoxic cell, a lymphocyte, an immune response modulator, an antigen receptor, an antigen-presenting cell, or a dendritic cell.

3. The method of claim 1, wherein the selecting one or more immune response components further comprises:

selecting one or more modulators of at least a part of at least one of a macrophage, a neutrophil, a cytotoxic cell, a lymphocyte, an immune response modulator, an antigen receptor, an antigen-presenting cell, or a dendritic cell.

6. The method of claim 1, wherein the selecting one or more immune response components further comprises:

selecting at least a part of one or more of an antibody, a recombinant antibody, a genetically engineered antibody, a chimeric antibody, a monospecific antibody, a bispecific antibody, a multispecific antibody, a diabody, a human antibody, a heteroantibody, a monoclonal antibody, a polyclonal antibody, a camelized antibody, a deimmunized antibody, an anti-idiotypic antibody, or an antibody fragment.

7. The method of claim 1, wherein the selecting one or more immune response components further comprises:

selecting one or more of a modulator of at least a part of at least one of an antibody, a recombinant antibody, a genetically engineered antibody, a chimeric antibody, a monospecific antibody, a bispecific antibody, a multispecific antibody, a diabody, a human antibody, a heteroantibody, a monoclonal antibody, a polyclonal antibody, a camelized antibody, a deimmunized antibody, an anti-idiotypic antibody, or an antibody fragment.

8. The method of claim 1, wherein the identifying an association of at least a computable portion of one or more agents with at least a part of an immune response further comprises:

identifying an association of at least a computable portion of at least one of an organism, a virus, a dependent virus, an associated virus, a bacterium, a yeast, a mold, a fungus, a protoctist, an archaea, a mycoplasma, a phage, a mycobacterium, an ureaplasma, a chlamydia, a rickettsia, a nanobacterium, a prion, an agent responsible for transmissible spongiform encephelopathy (TSE), a multicellular parasite, a protein, an infectious protein, a polypeptide, a polyribonucleotide, a polydeoxyribonucleotide, a polyglycopeptide, a polysaccharide, a nucleic acid, an infectious nucleic acid, a polymeric nucleic acid, a metabolic byproduct, a cellular byproduct, or a toxin.

4. (canceled)

5. (canceled)

9. (canceled)

10. (canceled)

11. (canceled)

12. (canceled)

13. (canceled)

14. (canceled)

15. (canceled)

16. (canceled)

17. A method, comprising:

accepting an input of one or more agents; and

identifying an association of at least a computable portion of one or more agents with at least a part of an immune response related to suppressing the one or more agents.

18. (canceled)

19. A method, comprising:

projecting a pattern of one or more changes relating to at least a computable portion of one or more agents; and

selecting one or more immune response components in response to said projecting.

20-58. -58. (canceled)